BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 667419)

  • 1. Antagonism of the effects on thermoregulation of delta9-tetrahydrocannabinol by clomipramine in the rat.
    Fennessy MR; Taylor DA
    Br J Pharmacol; 1978 Jun; 63(2):267-73. PubMed ID: 667419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biphasic nature of the effects of delta9-tetrahydrocannabinol on body temperature and brain amines of the rat.
    Taylor DA; Fennessy MR
    Eur J Pharmacol; 1977 Nov; 46(2):93-9. PubMed ID: 590330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of delta9-tetrahydrocannabinol on body temperature and brain amine concentrations in the rat at differnt ambient temperatures.
    Fennessy MR; Taylor DA
    Br J Pharmacol; 1977 May; 60(1):65-71. PubMed ID: 884391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-course of the effects of chronic delta 9-tetrahydrocannabinol on behaviour, body temperature, brain amines and withdrawal-like behaviour in the rat.
    Taylor DA; Fennessy MR
    J Pharm Pharmacol; 1982 Apr; 34(4):240-5. PubMed ID: 6124598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between body temperature and brain monoamines during the development of tolerance to delat9-tetrahydrocannabinol in the rat.
    Taylor DA; Fennessy MR
    Psychopharmacology (Berl); 1978 Apr; 56(3):279-85. PubMed ID: 418435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Antagonist"-precipitated withdrawal in the rat after chronic delta9-tetrahydrocannabinol treatment.
    Taylor DA; Fennessy MR
    J Pharm Pharmacol; 1978 Oct; 30(10):654-6. PubMed ID: 30825
    [No Abstract]   [Full Text] [Related]  

  • 7. The mechanism of action of delta 9-tetrahydrocannabinol on body temperature in mice.
    Davies JA; Graham JD
    Psychopharmacology (Berl); 1980; 69(3):299-305. PubMed ID: 6251505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothermia induced by delta9-tetrahydrocannabinol in rats with electrolytic lesions of preoptic region.
    Schmeling WT; Hosko MJ
    Pharmacol Biochem Behav; 1976 Jul; 5(1):79-83. PubMed ID: 996043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of (-)-trans-delta 9-tetrahydrocannabinol on regional brain levels and subcellular distribution of monoamines in the rat.
    Taylor DA; Fennessy MR
    Clin Exp Pharmacol Physiol; 1979; 6(5):541-8. PubMed ID: 498594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Withdrawal-like behaviour induced by inhibitors of biogenic amine reuptake in rats treated chronically with delta 9-tetrahydrocannabinol.
    Verberne AJ; Taylor DA; Fennessy MR
    Psychopharmacology (Berl); 1980; 68(3):261-7. PubMed ID: 6248916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of some pharmacological actions of morphine and delta9-tetrahydrocannabinol in the mouse.
    Bloom AS; Dewey WL
    Psychopharmacology (Berl); 1978 May; 57(3):243-8. PubMed ID: 97703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of coadministration of cannabinoids and morphine on nociceptive behaviour, brain monoamines and HPA axis activity in a rat model of persistent pain.
    Finn DP; Beckett SR; Roe CH; Madjd A; Fone KC; Kendall DA; Marsden CA; Chapman V
    Eur J Neurosci; 2004 Feb; 19(3):678-86. PubMed ID: 14984418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of delta9-tetrahydrocannabinol-induced hypothermia by fluoxetine in the rat.
    Malone DT; Taylor DA
    Br J Pharmacol; 1998 Aug; 124(7):1419-24. PubMed ID: 9723953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance to the cardiovascular effects of delta9-tetrahydrocannabinol in the rat.
    Adams MD; Chait LD; Earnhardt JT
    Br J Pharmacol; 1976 Jan; 56(1):43-8. PubMed ID: 1252665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of delta9-tetrahydrocannabinol with d-amphetamine, cocaine, and nicotine in rats.
    Pryor GT; Larsen FF; Husain S; Braude MC
    Pharmacol Biochem Behav; 1978 Mar; 8(3):295-318. PubMed ID: 652837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of (-)-delta9-tetrahydrocannabinol on reserpine-induced hypothermia in rats.
    Englert LF; Ho BT; Taylor D
    Br J Pharmacol; 1973 Oct; 49(2):243-52. PubMed ID: 4793331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delta9-tetrahydrocannabinol (Delta9-THC) prevents cerebral infarction via hypothalamic-independent hypothermia.
    Hayakawa K; Mishima K; Nozako M; Hazekawa M; Ogata A; Fujioka M; Harada K; Mishima S; Orito K; Egashira N; Iwasaki K; Fujiwara M
    Life Sci; 2007 Mar; 80(16):1466-71. PubMed ID: 17289082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
    Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perinatal delta9-tetrahydrocannabinol exposure reduces proenkephalin gene expression in the caudate-putamen of adult female rats.
    Corchero J; García-Gil L; Manzanares J; Fernández-Ruiz JJ; Fuentes JA; Ramos JA
    Life Sci; 1998; 63(10):843-50. PubMed ID: 9734704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Org 6582, chlorimipramine and desmethylimipramine on the depletion of biogenic amines from the rat brain in vivo.
    Kafoe WF; Leonard BE
    Biochem Pharmacol; 1977 Jun; 26(11):1083-4. PubMed ID: 880260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.